ASCO Genitourinary Cancers Symposium 2027

The ASCO Genitourinary Cancers Symposium is a three-day meeting on prostate, bladder, kidney and other GU cancers, held each February in San Francisco. ASCO runs it with ASTRO and the Society of Urologic Oncology.

Official site

Checked November 14, 2026

Reported attendance

5,850

total registrations · 2026

Reported exhibitors

Not published

How these are counted ↓

About ASCO Genitourinary Cancers Symposium 2027

The ASCO Genitourinary Cancers Symposium is a three-day scientific meeting on prostate, bladder, kidney and other GU cancers. The American Society of Clinical Oncology runs it with ASTRO and the Society of Urologic Oncology as cosponsors. The 2027 symposium runs February 11 to 13 at Moscone West in San Francisco, in person and online. ASCO counted 5,850 registrations at the 2026 meeting from 57 countries.

Sources: asco.org, events.jspargo.com

What happens at the ASCO Genitourinary Cancers Symposium

The symposium mixes oral abstracts, poster sessions, tumor boards and education sessions across GU cancers. ASCO's 2027 program overview sets the theme "Pioneering Breakthroughs, Optimizing Patient Outcomes."

Each day has its own focus. Thursday covers prostate cancer, Friday covers urothelial carcinoma, and Saturday covers kidney, adrenal, penile, urethral and testicular cancers.

Every day opens with an oral abstract session and closes the science with a rapid oral abstract session. Multidisciplinary tumor boards bring urologic, medical and radiation oncologists together with pathologists and radiologists.

Poster and Trials in Progress sessions run over lunch and into evening wine and cheese receptions. The program also lists poster walks, a trainee and early career luncheon and a Women in Genitourinary Cancers luncheon.

ASCO's own ASCO Daily News covers the meeting. Independent coverage of 2026 in CancerNetwork highlighted bladder and kidney cancer results.

ASCO's flagship meeting has its own page on this site, the ASCO Annual Meeting 2027.

What's new for ASCO GU 2027

The 2027 dates fall about two weeks earlier in the calendar than the 2026 edition. The exhibit enhancements list two new items, print-your-badge iPads and a registration confirmation bundle.

Abstract titles come out on January 5, 2027, and full abstracts on February 8, 2027. Both dates are on the symposium FAQ.

Who attends the ASCO Genitourinary Cancers Symposium

Clinicians and researchers in GU oncology make up most of the audience, with a large industry share. ASCO's 2026 registration numbers show 5,850 registrations in total.

Professional attendees by primary role
  • Medical Oncologist18%
  • Pharmaceutical Marketing and Sales13%
  • Clinical Oncologist13%
  • Urologist8%
  • Researcher8%
  • Medical Science Liaison4%
  • Oncology Fellow/Resident4%
  • Consultant3%
  • Pharmacist3%
  • Radiation Oncologist2%

Share of the 5,000 professional registrants who answered (96% responded). Top 10 of 21 roles shown.2026 · asco.org ↗

Top 5 countries in attendance
  • United States3,067
  • Canada233
  • Brazil160
  • Germany160
  • Japan145

2026 · asco.org ↗

2026 registrations by type
  • In-Person + Online Professionals4,200
  • Online-Only Professionals800
  • Exhibitors620
  • Media and Others230

2026 · asco.org ↗

That total held 5,000 professional attendees, 620 exhibitor registrations and 230 media and others. Of the professionals, 4,200 registered for in-person plus online access and 800 for online only.

Medical oncologists were the largest professional group at 18%. Pharmaceutical marketing and sales staff and clinical oncologists followed at 13% each, then urologists and researchers at 8% each.

The United States sent 3,067 attendees in 2026. Canada sent 233, Brazil and Germany 160 each, and Japan 145.

ASCO's exhibitor site gives an attendee to exhibitor ratio of 28 to 1.

Attendance and exhibitors by year

As the organizer reports them. What's counted varies between events, so compare with care.

EditionAttendance
2026

5,850total registrations, incl. 5,000 professionals (800 online only), 620 exhibitor registrations and 230 media and othersASCO's 2026 registration numbersasco.org ↗

Companies exhibiting and sponsoring at the ASCO GU Cancers Symposium 2027

Pharma, biotech and diagnostics companies dominate the 2027 exhibitor directory. The list below comes from that directory and ASCO's featured exhibitors page as of 14 November 2026.

Sponsors (6)Astellas, AstraZeneca, Bristol Myers Squibb and 3 more
Partners (2)Society of Urologic Oncology, American Society for Radiation Oncology (ASTRO)
Exhibitors (29)AbbVie, American Society for Radiation Oncology (ASTRO), Amgen Inc. and 26 more
Attending (1)Merck

Large drugmakers include AbbVie, Astellas, AstraZeneca, Bayer, Bristol Myers Squibb, Daiichi Sankyo and Pfizer Oncology. Diagnostics and data companies include Caris Life Sciences, Foundation Medicine, Natera, Quest Diagnostics and Tempus.

Radiopharmaceutical companies such as Curium, Clarity Pharmaceuticals, Blue Earth Diagnostics and Telix also have booths. Professional groups exhibiting include ASTRO and the Canadian Urological Association.

Companies also present data without being listed as exhibitors. Merck said it would present bladder and kidney cancer data at the 2026 symposium.

Exhibitors at the ASCO Genitourinary Cancers Symposium

Exhibits are tabletop displays in the room that also holds posters and meals. ASCO's exhibit page prices a table at $12,500.

The package includes a draped counter-high table, five full registrations and a reference list of attendees. Nonprofits get three registrations. It also adds directory listings and priority points toward the 2028 ASCO Annual Meeting.

Exhibitors can rent private meeting rooms in Moscone West at Standard, Premium and Deluxe levels. Industry Expert Theater sessions cost $45,000 for up to 50 in-person attendees.

Branding add-ons sit on the enhancements page, and several were already sold in November 2026. A featured listing in the 2027 exhibitor directory costs $1,000.

Exhibits open only on February 11 and 12, 2027, per the exhibitor general information page. Booking runs through SPARGO, ASCO's exhibit contractor.

Exhibitors use the Capture! service from SPARGO for lead retrieval. This site compares lead retrieval apps in general.

Sponsors and partners at the ASCO Genitourinary Cancers Symposium

Industry support runs through Conquer Cancer, the ASCO Foundation, rather than a sponsor package. The symposium site lists Gold Sponsorship Donors Astellas, AstraZeneca, Bristol Myers Squibb, Eisai and Novartis.

Lantheus is listed as a Genitourinary Cancers Symposium Donor at the Innovator level. ASCO doesn't say which edition these listings cover.

The cosponsors page names ASCO, the American Society for Radiation Oncology and the Society of Urologic Oncology. ASTRO and SUO members get a registration discount.

Advertising, support and ancillary events are explained on the additional opportunities page. Our guide to event sponsorship software covers how organizers sell these packages.

The event's tech

We couldn't identify a third-party registration platform on the event's website.

Which platforms run B2B event registration →

ASCO GU attendee list, exhibitor list and sponsor list

Official floor plan ↗

ASCO publishes its exhibitor list but doesn't sell an attendee email list. The online exhibitor directory lists each company with booth numbers.

ASCO's registration page warns about attendee list scams. It says it doesn't sell or transfer attendee information to third parties for commercial purposes.

ASCO says it works with InFocus for mailing list sales and never sells email addresses. Exhibitors also get a reference list of attendees in their package.

The donor list appears at the foot of the symposium home page. For other ways to research an audience, see how to find who's attending an event and our event intelligence platforms roundup.

See who's attending ASCO Genitourinary Cancers Symposium

Organizers don't publish attendee lists. These event intelligence platforms show which companies and roles are likely to attend and help you book meetings. How to find who's attending

Speakers at the ASCO GU Cancers Symposium 2027

ASCO has named four featured speakers for 2027 on the symposium home page. W. Kimryn Rathmell of The Ohio State University Comprehensive Cancer Center gives the keynote.

Jose A. Karam of The University of Texas MD Anderson Cancer Center chairs the 2027 symposium. Alberto Bossi of Amethyst Radiotherapy Group in France is Chair-Elect.

Andrea B. Apolo of the National Cancer Institute is Immediate Past Chair. The full faculty for each session will appear in the ASCO Meetings App and online program.

Abstract first authors upload posters through ASCO's Speaker Center by January 25, 2027.

Dates, venue and getting there

The 2027 symposium runs February 11 to 13 at Moscone West, 800 Howard Street, San Francisco. ASCO's exhibitor information page gives the address and exhibit hours.

Exhibits open 7 a.m. to 6.45 p.m. on Thursday and 7 a.m. to 5.45 p.m. on Friday. Exhibitor move-in is the afternoon of Wednesday, February 10.

The venue's event listing for ASCO GU describes an earlier February 13 to 15 edition at the Moscone Center.

ASCO books hotels through SPARGO and asks attendees to reserve only through its website. The hotel deadline is December 16, 2026.

Tickets and registration for ASCO GU 2027

Registration is open to the cancer care community, with lower rates for ASCO members. The 2027 registration page lists early in-person fees from $975 for member physicians and $1,495 for nonmembers.

Industry and nonmedical attendees pay $1,835 in person by December 16, 2026, rising to $2,060 from January 23, 2027. Online-only industry passes start at $1,465.

Trainees, affiliated health professionals and patient advocates get reduced rates. Patient advocates can join online for free.

The in-person fee covers sessions, posters, exhibits, on-demand content, breakfasts, boxed lunches and poster receptions. Prices were checked in November 2026.

You can switch from in-person to online and get the difference back until February 7, 2027. Onsite registration closes at 3 p.m. Pacific on February 13.

History of the ASCO Genitourinary Cancers Symposium

The symposium began in 2005 as a prostate cancer meeting. An ASCO Daily News podcast marking its 20th anniversary says 1,035 people came to the first meeting in San Francisco.

The founding cosponsors were ASCO, ASTRO, SUO and the Prostate Cancer Foundation. The meeting moved between San Francisco and Florida before settling in San Francisco.

It later grew to cover all GU cancers. The 2026 edition ran February 26 to 28 in San Francisco and online.

Frequently asked questions

When is ASCO Genitourinary Cancers Symposium 2027?
ASCO Genitourinary Cancers Symposium 2027 runs February 11 to 13, 2027 in San Francisco, United States, at Moscone West.
Where is ASCO Genitourinary Cancers Symposium held?
ASCO Genitourinary Cancers Symposium takes place in San Francisco, United States, at Moscone West. It's held every year.
How many people attend ASCO Genitourinary Cancers Symposium?
The organizer reported 5,850 total registrations, incl. 5,000 professionals (800 online only), 620 exhibitor registrations and 230 media and others for the 2026 edition. Organizers count differently, so compare figures with care.
Who organizes ASCO Genitourinary Cancers Symposium?
ASCO Genitourinary Cancers Symposium is organized by American Society of Clinical Oncology.
What is ASCO GU?
It's the ASCO Genitourinary Cancers Symposium, a three-day meeting on prostate, bladder, kidney and other GU cancers. ASCO runs it with ASTRO and SUO as cosponsors.
When is ASCO GU 2027?
ASCO GU 2027 runs February 11 to 13, 2027 at Moscone West in San Francisco. Exhibits are open February 11 and 12.
Who attends the ASCO Genitourinary Cancers Symposium?
Oncologists, urologists, researchers and industry teams. In 2026, ASCO counted 5,850 registrations from 57 countries, and medical oncologists were the largest group at 18%.
What companies are exhibiting at ASCO GU 2027?
The 2027 exhibitor directory lists AbbVie, Astellas, AstraZeneca, Bayer, Bristol Myers Squibb, Daiichi Sankyo, Pfizer Oncology and Tempus, among others.
How much does it cost to exhibit at ASCO GU?
An exhibit table costs $12,500 for 2027, with five full registrations included. Industry Expert Theater sessions cost $45,000.
How much is registration for ASCO GU 2027?
Early in-person rates start at $975 for member physicians and $1,495 for nonmembers. Industry attendees pay $1,835 by December 16, 2026.
Can I attend ASCO GU online?
Yes. ASCO sells online-only passes with live streams and on-demand content, from $780 for member physicians before December 16, 2026.
Who's speaking at ASCO GU 2027?
W. Kimryn Rathmell of The Ohio State University Comprehensive Cancer Center gives the 2027 keynote. Jose A. Karam of MD Anderson chairs the symposium.
Who sponsors the ASCO Genitourinary Cancers Symposium?
Support comes through Conquer Cancer, the ASCO Foundation. The symposium site lists Gold donors Astellas, AstraZeneca, Bristol Myers Squibb, Eisai and Novartis.
Can I buy the ASCO GU attendee list?
No. ASCO says it doesn't sell attendee information and warns exhibitors about list scams. It sells mailing lists only through InFocus and never sells email addresses.
When are ASCO GU 2027 abstracts released?
Abstract titles come out on January 5, 2027, and full abstracts on February 8, 2027, per the symposium FAQ.